Sectors

Novel Group and CAA are set to exit NuOrder after the business-to-business e-commerce platform agreed to an acquisition by Lightspeed.

Mayo Clinic returned to reinvest in the genomics platform developer three years after backing its series B round alongside Illumina.

Returning investor Mitsubishi has joined fellow corporates BHP Group and Freeport-McMoRan for a round that increased the copper extraction technology provider's total funding to $100m.

TusStar has participated in a series A round for smart robotics technology developer TimeRiver.

SoftBank is set to exit smart scheduling software developer X.ai as its Vision Fund 2 invests in artificial intelligence technology unicorn AInnovation.

Munich Re and Centene-backed digital health software provider Babylon Health is set to get a public listing through the deal.

SoftBank Vision Fund 2 led a series C-plus round for the home remodelling materials marketplace, after Tencent Investment participated in its series C round in December.

BMW i Ventures, Dell Technologies Capital and Robert Bosch Venture Capital are in line to exit the manufactiuring services marketplace, which has filed for a $100m offering.

Chuanghong Fund’s first close included corporate LPs Century Golden Resources Group, Country Garden, Joyoung and Hunan TV & Broadcast Intermediary.

Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.

IP Group sold a $5m stake to incoming shareholder Celltrion as part of a series A round for Iksuda, a spinout of Bath originally called Glythera.